Introduction
============

*Althaea rosea* (Linn.) (Althaea, Malvaceae) is a common perennial ornamental plant ([@B24]), generally known as hollyhock or marshmallow, and is usually grown in gardens, parks, river banks, and salt marshes. The plant is native to China and is now found in tropical and temperate regions around the world, including the Middle East, the Mediterranean, Central Asia, and Southern Europe ([@B4]). The medicinal parts of *A. rosea* (*A. rosea*) include flowers, leaves, roots, and seeds ([@B14]). *A. rosea* flowers have been used in traditional Uyghur medicine to treat a variety of diseases for a long time as anti-inflammatory agents, febrifuge, palliatives, and astringents ([@B12]). However, the material basis of its anti-inflammatory effects remains to be elucidated ([@B15]). Therefore, the isolation and identification of small molecules and their biological activities are important for understanding the mode of action (MOA) of *A. rosea* flowers and their effects on physiology ([@B23]). Under these conditions, ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC/Q-TOF-MS/MS) provides accurate structural information about the bioactive compounds for the separation and identification of mixtures ([@B21]; [@B22]). High throughput screening based on biological active systems is a rapid method of assaying potential inhibitors against a specific target ([@B11]; [@B1]). The combination of the two methods can quickly provide structural and activity information for complex samples and provides a basis for the screening of pharmacological substances.

Inflammation is a basic pathological process in which a biological tissue is stimulated by trauma or infection to promote a defensive response. The main consequence of the increase in inflammatory signaling is the upregulation of nuclear factor-κB (NF-κB) and subsequent damage, and the intensity of the damage depends on the type of activation of the NF-κB dimer ([@B10]; [@B17]). NF-κB plays a key role in the expression of many pro-inflammatory genes caused by viral and bacterial infections. This expression leads to the synthesis of cytokines and chemokines, including interleukins IL-6, IL-8, RANTES, IL-11 and eosinophil chemotactic factors ([@B6]; [@B13]; [@B25]), causing an inflammatory stress response. Screening based on NF-κB inhibitory activity will help to identify effective and novel anti-inflammatory drugs ([@B3]).

The inflammatory effect is achieved through activation of phagocytic activity, increased expression of NF-κB and chemokines (including tumor necrosis factor (TNF-α, IL-1, IL-6, IL-8, and IL-12) ([@B18]). Many reports have demonstrated that LPS (lipopolysaccharide) treatment can stimulate cells to increase NO, ROS, and cytokine production ([@B2]). Selecting appropriate cell lines for *in vitro* models is a useful method to evaluate immunomodulatory effects by measuring the synthesis of inflammatory molecules in response to different stimuli. This provides an effective clue for screening the core structure of natural products and developing effective small molecule inhibitors that selectively target NF-κB activation.

In this paper, an integrated strategy combining UPLC/Q-TOF-MS/MS with biological evaluation for NF-κB inhibitors was proposed. *A. rosea* flowers were investigated using the combined method of chemical component identification and bioactivity detection. Potential bioactive compounds were identified according to the mass spectrometry data and screened by NF-κB activity assay system simultaneously. In conjunction with our subsequent studies of enzyme-linked immune sorbent assay (ELISA) evaluation of inflammatory factors, the anti-inflammatory compounds of *A. rosea* flowers were clearly identified and validated. Compared with traditional chromatographic separation, the strategy of integrating UPLC/Q-TOF-MS/MS and bioactivity assay is more convenient and reliable. This strategy not only can be used for general component identification but also can directly screen trace active components from complex matrices.

Materials and Methods
=====================

Reagents and Chemicals
----------------------

*Althaea rosea* flowers were purchased from Changan Chinese Herbal Medicine Co., Ltd. (Anguo, Hebei, China). The reporter plasmids pGL4.32 and pRL-TK were purchased from Promega (WI, United States). Human tumor necrosis factor alpha (TNF-α) was purchased from PeproTech (Rocky Hill, NJ, United States). Dexamethasone (Dex) was purchased from Sigma Chemical Co., Ltd. (St Louis, MO, United States). The ELISA kit (IL-6 and IL-8) was purchased from Biosource International Life Technologies Co., (Camarillo, CA, United States). All reagents for cell culture were purchased from Gibco Life Technologies (Rockville, MD, United States). The acetonitrile (CH~3~CN) for the UPLC/Q-TOF-MS/MS was UPLC-grade and was purchased from Thermo Fisher (Waltham, MA, United States). Deionized water was obtained by the Milli-Q system (Bedford, MA, United States). The reference compounds protocatechuic acid, caffeic acid, ferulic acid; quercetin, luteolin, naringenin, and kaempferol were purchased from Yifang Technologies (Tianjin, China). All other reagents used were of analytical grade.

Sample Preparation
------------------

One hundred grams of *A. rosea* flowers was boiled in 1 L of 75% ethanol. The solution was filtered and evaporated to dryness (10.28 g). The concentrate was dissolved in water to a 10 mg/mL concentration and filtered through a filter (0.22 μm) membrane and stored at 4°C.

Liquid Chromatography Conditions
--------------------------------

The Waters Acquity UPLC Instrument System (Waters Co., United States) was controlled by MassLynx V4.1 software (Waters Co., United States). Separation was carried out using an Acquity BEH C~18~ column (2.1 mm × 100 mm, 1.7 μm; Waters Co., United States). The column temperature was maintained at 30°C, and the flow rate was 0.40 mL/min. The injection volume of the test sample was 2 μL. The mobile phase was CH~3~CN (A) and 0.5% aqueous formic acid (B), using a gradient elution. The steps were as follows: 2--11% A, 0--6 min; 11--16% A, 6--10 min; 16--17% A, 10--13 min; 17--19% A, 13--15 min; 19--25% A, 15--18 min; 25--100% A, 18--21 min; and 100% A in 21--22 min.

Mass Spectrometry Analysis
--------------------------

The components of *A. rosea* flowers were identified using a Waters Q-TOF Premier and Electrospray Ionization (ESI) system (Waters MS Technologies, Manchester, United Kingdom). At the same time, ESI-MS spectra were obtained in positive ion and negative ion modes. The positive mode capillary voltage was set to 2.8 kV, and the negative mode was 2.2 kV. The sample cone voltage was set to 40 V, and the source temperature was 120°C. The sample atomization and auxiliary gas were high purity nitrogen. The rate of atomizing gas was 800 L/h, the cone gas was 50 L/h, and the degassing temperature was set to 400°C. The Q-TOF Premier acquisition rate was 0.1 s, and the inter-scan delay was 0.02 s. The argon gas used as the collision gas was maintained at a pressure of 5.3 × 10^-5^ Torr. The instrument was operated in wide-pass mode (100--1500 Da) using the first resolution quadrupole. Leucine enkephalin acetate was used as a reference material to lock the mass (\[M+H\]^+^ = 555.2931, \[M-H\]^-^ = 553.2775).

Sample Preparation for Bioactivity Assay
----------------------------------------

The fractions separated by UPLC were collected into 96 deep well plates (2.2 mL) every 30 s and then evaporated to dryness at 40°C in a vacuum oven. The 44 dried residues were dissolved in Dulbecco's Modified Eagle Medium (DMEM) cell culture medium (100 μL) for luciferase reporter activity assay. The collection process of the components was repeated five times for the activity test.

Anti-inflammatory Activity Tests *in vitro*
-------------------------------------------

HEK293T cells were purchased from the American Type Culture Collection (Rockville, MD, United States). The cells were cultured in DMEM containing 10% fetal calf serum (FBS), 0.1 mg/mL streptomycin and 100 U/mL penicillin, and grown at 37°C, 5% CO~2~. Plasmid pGL4.32 (100 ng per well) and Renilla luciferase reporter vector plasmid pRL-TK (9.6 ng per well) were co-transfected into HEK 293T cells using the NF-κB luciferase reporter plasmid pGL4.32 (100 ng per well).

The cells were incubated for 1 day before adding seven commercial anti-inflammatory compounds. The cells were pre-treated with the representative compounds (protocatechuic acid, caffeic acid, ferulic acid; quercetin, luteolin, naringenin, and kaempferol, 10 mg/L) and Dex (4 mg/L) for 1 h and then stimulated with TNF-α (10 ng/mL) for 6 h. After stimulating the cells, HEK 293T cells were lysed and assayed for luciferase activity using a dual luciferase reporter assay system according to the manufacturer's instructions (Promega, Madison, WI, United States).

Measurement of Chemokines (IL-6 and IL-8)
-----------------------------------------

After stimulating the cells with TNF-α (10 μg/L), the potential bioactive compound (10 mg/L) and Dex (4 mg/L) were added, then commercial enzyme-linked immunosorbent assay kits (Pierce/Endogen, Rockford, IL, United States) were used to measure the release of IL-6 and IL-8 from the supernatants of HEK 293T cells. We collected the supernatant and measured the absorbance of each sample at 450 nm using a microplate reader (Bio-Rad Model 680, Hercules, CA, United States). The levels of chemokines (IL-6 and IL-8) were determined from the standard curve and expressed as pg/mL.

Statistical Analysis
--------------------

All assays were repeated three times and are presented as the mean ± standard deviation (SD) and analyzed by analysis of variance (ANOVA) followed by Dunnett's test. The significance of the differences was determined using GraphPad Prism 5 (Graph Pad Software Inc., San Diego, CA, United States), and *p* \< 0.05 was considered to be statistically significant.

Results and Discussion
======================

Chemical Identification of *A. rosea* Flowers
---------------------------------------------

UPLC/Q-TOF-MS/MS was used to separate the extract of *A. rosea* flowers and obtain the accurate molecular weight of the components. Most of the chromatographic peaks were completely separated (Figures [1A,B](#F1){ref-type="fig"}). The mass spectra of the compounds were compared with the mass spectra of the standard or literature data to obtain 27 compounds (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} and Supplementary Table [S1](#SM1){ref-type="supplementary-material"} in the [Supplementary information](#SM1){ref-type="supplementary-material"}).

![UPLC/Q-TOF-MS/MS and bioactivity analysis of the *Althaea rosea* flowers. **(A)** Total Ion Chromatography (TIC) chromatograms in positive ESI mode. **(B)** TIC chromatograms in negative ESI mode. **(C)** Bioactivity chromatograms obtained via the luciferase reporter assay system for NF-κB inhibition. The peak numbers are consistent with those reported in Table [1](#T1){ref-type="table"}.](fpls-09-01975-g001){#F1}

Assay of NF-κB Inhibition
-------------------------

A total of 44 fractions were obtained by UPLC separation (Figure [1C](#F1){ref-type="fig"}). Through the activity test, some fractions caused significant inhibition of NF-κB. Detailed mass spectral information for these fractions is listed in Table [1](#T1){ref-type="table"}, and 12 compounds were further identified based on their ionic fragmentation behavior. These compounds were divided into four groups according to their chemical structures: phenolic acid, hydroxycinnamic acid, flavonoid, and dihydroflavone (Figure [2](#F2){ref-type="fig"}). Potential anti-inflammatory compounds were quantified according to the labeling curve of the commercial standard, and the data are presented in Table [1](#T1){ref-type="table"}. The highest content component was quercetin and its glycoside compound. The total content of quercetin and its derivatives reached 1.148%.

###### 

MS/MS data in (±) ESI modes and the identification results for the bioactive compounds in Althaearosea.

       Time          MS-ESI     MS-ESI     Error                                                                                                                                  Content
  ---- ------- ----- ---------- ---------- ----------- ------------------------------ ----------------- ------------------------------------------------------------------------- ---------
  1    1.63    Neg              153.0505   2.072       153 \[M-H\]^-^                 C~7~H~6~O~4~      Protocatechuic acid                                                       113.7
                                                       136 \[M-H-H~2~O\]^-^                                                                                                       
  2    5.1     PN    181.0356   179.0353   3.314(+)    179\[M-H\]^-^                  C~9~H~8~O~4~      Caffeic acid                                                              340.9
                                                       145\[M-H-OH-OH\]^-^                                                                                                        
                                                       135\[M-H-COO\]^-^                                                                                                          
  3    5.95    PN    195.0509   193.0505   4.144(+)    193\[M-H\]^-^                  C~10~H~10~O~4~    Ferulic acid                                                              295.6
                                                       176\[M-H-OH\]^-^                                                                                                           
                                                       149\[M-H-OH-OCH~3~\]^-^                                                                                                    
  4    7.662   PN    611.1611   609.1606   0.654(+)    609\[M-H\]^-^                  C~27~H~30~O~16~   Rutin                                                                     550.1
                                                       463\[M-H-Glu\]^-^                                                                                                          
                                                       301\[M-H-Glu-\]^-^                                                                                                         
  5    9.5     PN    611.1388   609.1394   -1.145(+)   609\[M-H\]^-^                  C~30~H~26~O~14~   Quercetin- 3- O- ( 6″- O- *trans*- p- coumaroyl) -β- D- glucopyranoside   4371
                                                       301\[M-H- coumaroyl-Glu\]^-^                                                                                               
  6    9.51    PN    465.1031   463.1029   0.430(+)    463\[M-H\]^-^                  C~21~H~20~O~12~   Quercetin 4′- O-β- D- glucopyranoside                                     3635
                                                       927\[2M-H\]^-^                                                                                                             
                                                       301\[M-H-Glu\]^-^                                                                                                          
  7    11.89   PN    449.1001   447.1013   1.566(-)    895\[2M-H\]^-^                 C~21~H~20~O~11~   Astragalin                                                                79.14
                                                       447\[M-H\]^-^                                                                                                              
                                                       285\[M-H-Glu\]^-^                                                                                                          
  8    13.56   Neg              463.1028   -0.432      463\[M-H\]^-^                  C~21~H~20~O~12~   Quercetin- 3- O-β- D- glucopyranoside                                     2873
                                                       301\[M-H-Glu\]^-^                                                                                                          
  9    16.47   PN    303.0497   301.0506   2.325(+)    301\[M-H\]^-^                  C~15~H~10~O~7~    Quercetin                                                                 606.1
                                                       601\[2M-H\]^-^                                                                                                             
  10   16.59   PN    287.0448   285.0456   -7.367(-)   285\[M-H\]^-^                  C~15~H~10~O~6~    Luteolin                                                                  397.5
                                                       331\[M+HCOOH-H\]^-^                                                                                                        
                                                       571\[2M-H\]^-^                                                                                                             
  11   18.96   PN    273.0694   271.0688   0.518       271\[M-H\]^-^                  C~15~H~12~O~5~    Naringenin                                                                285.2
                                                       254\[M-H-OH\]^-^                                                                                                           
  12   20.12   Neg              285.0463   4.911       285\[M-H\]^-^                  C~15~H~10~O~6~    Kaempferol                                                                87.13
                                                       268\[M-H-OH\]^-^                                                                                                           
                                                       571\[2M-H\]^-^                                                                                                             
                                                                                                                                                                                  

Neg, negative ion mode; PN, positive and negative ion mode.

![Chemical structures of the bioactive compounds in *Althaea rosea* flowers.](fpls-09-01975-g002){#F2}

Demonstration of the Bioactivity of NF-κB Inhibitors of *A. rosea* Flowers
--------------------------------------------------------------------------

From the four types of compounds, we selected seven compounds as representatives, namely, protocatechuic acid, caffeic acid, ferulic acid, quercetin, luteolin, naringenin, and kaempferol. A representative sample was added to TNF-α-stimulated HEK 293T and evaluated using a luciferase reporter assay system to investigate whether the compounds were effective in inhibiting the release of NF-κB. To evaluate inhibition of potential inhibitors in *A. rosea* flowers, Dex (4 mg/L) was used as a positive control. The inhibition profiles are shown in Figure [3](#F3){ref-type="fig"}. Compared with the model group, the seven compounds exhibited similar NF-κB inhibition (*p* \< 0.05). As expected, the potential anti-inflammatory compounds were significantly more active than the extracts, with IC~50~ values of 7.049, 1.094, 5.657, 1.568, 6.351, and 2.442 mg/L, respectively. However, the extract had an IC~50~ value of 211.8 mg/L (Figure [4](#F4){ref-type="fig"}).

![Confirmation of NF-κB inhibitors from *Althaea rosea* flowers by the luciferase reporter assay system. Each bar represents the mean ± SEM, *n* = 5 per group.](fpls-09-01975-g003){#F3}

![Determination of IC~50~ of representative compounds. **(A)** The inhibition curves of representative compounds. **(B)** The IC~50~ values of representative compounds.](fpls-09-01975-g004){#F4}

Confirmation of Inhibition of Inflammatory Factor Production (IL-6 and IL-8)
----------------------------------------------------------------------------

Further measures of inflammatory factors (IL-6 and IL-8) were used to determine the anti-inflammatory effects of potential NF-κB inhibitors. As shown in Figure [5](#F5){ref-type="fig"}, all seven compounds reduced the expression of IL-6 and IL-8 (*p* \< 0.05); further confirming the anti-inflammatory effects of the four structural types of compounds in *A. rosea* flowers. Among them, 10 μg/mL of ferulic acid, quercetin, and naringenin inhibited the production of inflammatory factors, which was very similar to the effect of 4 mg/L Dex. This indicates that ferulic acid, quercetin, and naringenin are relatively strong anti-inflammatory inhibitors in *A. rosea* flowers.

![Effects of representative compounds of NF-κB inhibitor on IL-6 and IL-8 expression in TNF-α-induced HEK 293 T. Error bars indicate SEM, *n* = 4. ^∗∗^*p* \< 0.01 vs. model group; ^∗∗∗^*p* \< 0.001 vs. model group; ^\#\#\#^*p* \< 0.001 vs. control group.](fpls-09-01975-g005){#F5}

Discussion
==========

UPLC/Q-TOF-MS/MS has been developed and validated as an upgrade to traditional chromatographic methods for the separation and determination of trace substances in complex matrices ([@B19]). In this study, based on the combination of UPLC/Q-TOF-MS/MS technology and biological activity screening, we screened potential NF-κB inhibitors in *A. rosea* flowers rapidly and accurately. Subsequently, the inhibitory effect of potential inhibitors on inflammatory factor production was evaluated *in vitro*. Some of the compounds with high activity would likely be ignored when using traditional screening methods due to the low content when using the inhibition activity assay. Integrating MS identification and bioactivity validation was more sensitive and reliable than the conventional methods, not only in the detection and identification of constituents in a complex matrix but also in screening potential lead compounds. This method is sensitive, and the detailed method validation is complete. Information on potential inhibitors provided here will facilitate the development of new drugs and the development of plant resources ([@B16]). We demonstrate here that this integrated system has advantages in separation, structural identification, and bioactivity analysis of hit compounds ([@B8]; [@B5]).

The 293T cell line is a derivative of the 293T (293tsA1609neo) cell line. 293T is a highly transfectable derivative of the 293 cell line into which the temperature sensitive gene for SV40 T-antigen was inserted. These cells constitutively express the simian virus 40 (SV40) large T antigen, and clone 17 was selected specifically for its high transfect ability ([@B9]). Therefore, we selected HEK293T as a vector for screening anti-inflammatory active compounds. NF-κB plays a key role in the expression of various pro-inflammatory genes caused by infections such as bacteria and viruses. The main consequence of inflammation is the upregulation of nuclear factor-κB (NF-κB) and subsequent damage. This upregulation leads to the synthesis of cytokines and chemokines, including interleukins IL-6, IL-8, RANTES, and IL-11, which in turn cause a series of stress responses to achieve inflammatory effects ([@B25]). Although screening based on NF-κB inhibitory activity will help to identify effective and novel anti-inflammatory drugs, it is also likely to cause certain false positives ([@B3]). Therefore, it is necessary to further confirm activity with the detection of downstream inflammatory factors such as IL-6 and IL-8.

We hypothesized that the 12 potential hit compounds are active ingredients, and the synergy between the various components leads to the specific anti-inflammatory effects of *A. rosea* flowers ([@B7]). Previous studies have shown that ferulic acid, caffeic acid, rutin, and quercetin can reduce the activation of NF-κB and have a significant anti-inflammatory effect ([@B3]). In particular, quercetin exhibited a remarkable ability to inhibit the production of inflammatory factors such as NF-κB, IL-6, and IL-8 in this study. This strategy clearly demonstrates that mass spectrometry fingerprinting combined with bioactivity assays is a powerful tool for improving the screening and identification of potential active compounds in plants.

*Althaea rosea* is commonly used as a Uighur drug and ornamental plant with a small range of applications, and its cultivation range and economic value need to be further developed. It has been found that *A. rosea* flowers contain a strong anti-inflammatory compound, quercetin. The latest research demonstrates that quercetin has other important effects. Quercetin could selectively eliminate senescent cells, reduces the number of naturally occurring senescent cells, and secretes fragile-associated pro-inflammatory cytokines in human adipose tissue explants ([@B20]). Our study found that quercetin and its glycosides are concentrated in *A. rosea* flowers. This will certainly enhance the cultivation value of *A. rosea*, making it a botanical source of important health and pharmaceutical compounds.

Conclusion
==========

The high-efficiency separation and structural identification information provided by UPLC/Q-TOF-MS/MS, combined with the high sensitivity activity evaluation of the luciferase reporter gene detection system, enables simultaneous screening of trace samples obtained by chromatographic separation. The system has important application for the screening of trace active ingredients in complex systems. Using this integrated system, we screened and validated potential NF-κB inhibitors in *A. rosea* flowers. The anti-inflammatory effect and active ingredients of rose flower are clarified, which furthers our understanding of the medicine's mechanism of action and promotes the development of lead compounds. In addition, the discovery of quercetin, an important compound in *A. rosea* flower, will also increase the planting value of *A. rosea*, which is conducive to the development of medicinal plants.
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